CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.11
+0.04 (0.56%)
May 22, 2026, 12:33 PM EDT - Market open
CorMedix Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, CorMedix stock has a consensus rating of "Strong Buy" and an average price target of $15. The average 1-year stock price forecast is 85.07% higher than the current stock price, while the lowest is $13 (+60.39%) and the highest is $19 (+134.42%).
Price Target: $15 (+85.07%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CorMedix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +72.73% | Apr 28, 2026 |
| Citizens | Citizens | Buy Reiterates $19 | Buy | Reiterates | $19 | +134.42% | Apr 28, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +72.73% | Apr 28, 2026 |
| Needham | Needham | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +85.07% | Apr 27, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +72.73% | Apr 27, 2026 |
Financial Forecast
Revenue This Year
333.74M
from 311.71M
Increased by 7.07%
Revenue Next Year
303.15M
from 333.74M
Decreased by -9.17%
EPS This Year
0.67
from 2.04
Decreased by -66.96%
EPS Next Year
0.43
from 0.67
Decreased by -36.75%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 362.7M | 386.9M | ||||||
| Avg | 333.7M | 303.2M | ||||||
| Low | 298.4M | 276.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 16.3% | 15.9% | ||||||
| Avg | 7.1% | -9.2% | ||||||
| Low | -4.3% | -17.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.09 | 1.31 | ||||||
| Avg | 0.67 | 0.43 | ||||||
| Low | 0.42 | 0.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -46.5% | 94.7% | ||||||
| Avg | -67.0% | -36.7% | ||||||
| Low | -79.3% | -98.5% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.